The efficacy and safety of a novel PD-1/CTLA-4 bispecific antibody cadonilimab (AK104) in advanced non-small cell lung cancer: A multicenter retrospective observational study
新型PD-1/CTLA-4双特异性抗体cadonilimab (AK104)治疗晚期非小细胞肺癌的疗效和安全性:一项多中心回顾性观察研究
期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15455
Li, Hongxin; Zhao, Wen; Li, Chengming; Shen, Hongchang; Li, Meiying; Wang, Chengjun; Han, Chunyan; Yi, Cuihua; Wang, Jun; Meng, Xue; Liu, Lian; Yu, Shuwen; Li, Jisheng